Basics Array Technologies, Inc. Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. IPO Date: October 15, 2020 Sector: Technology Industry: Solar Market Cap: $1.38B Activated in VL: True Average Daily Range Avg Daily Range: $0.52 | 3.29% Avg Daily Range (30 D): $0.34 | 3.81% Avg Daily Range (90 D): $0.30 | 3.93% Institutional Daily Volume Avg Daily Volume: 4.4M Avg Daily Volume (30 D): 5.8M Avg Daily Volume (90 D): 7.21M Trade Size Avg Trade Size (Sh.): 123 Avg Trade Size (Sh.) (30 D): 140 Avg Trade Size (Sh.) (90 D): 162 Institutional Trades Total Inst.Trades: 5,903 Avg Inst. Trade: $2.28M Avg Inst. Trade (30 D): $2.85M Avg Inst. Trade (90 D): $2.25M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $5.05M Avg Closing Trade (30 D): $5.51M Avg Closing Trade (90 D): $4.99M Avg Closing Volume: 362.28K     News Sep 28, 2025 @ 11:30 AM Is Nextracker Stock a Buy Now? Source: Leo Sun Aug 21, 2025 @ 12:00 PM Shoals Technologies Group Appoints Aaron Zadeh as ... Source: Shoals Technologies Group Aug 14, 2025 @ 8:15 PM ARRAY Technologies Completes Acquisition of APA So... Source: Globe Newswire Jun 25, 2025 @ 1:50 AM Array Technologies Announces Pricing of Upsized Of... Source: Array Technologies, Inc. Jun 18, 2025 @ 12:16 PM Array Technologies Boosts Solar Play With $179 Mil... Source: Nabaparna Bhattacharya Financials   TTM Q1 2025 Q3 2024 Basic EPS $.19 $.02 $-1.02 Diluted EPS $.19 $.02 $-1.02 Revenue $ 362.24M $ 302.36M $ 231.41M Gross Profit $ 97.12M $ 76.43M $ 78.32M Net Income / Loss $ 43.26M $ 16.75M $ -141.35M Operating Income / Loss $ 46.38M $ 27.28M $ -132.68M Cost of Revenue $ 265.12M $ 225.94M $ 153.09M Net Cash Flow $ 29.28M $ -14.65M $ 50.05M PE Ratio 49.03